Closing Bell: Cipher Pharmaceuticals Inc down on Tuesday (CPH)
In today's trading, shares of Cipher Pharmaceuticals Inc opened at $8.91 and closed at $8.80. It traded at a low of $8.80 to a high of $9.11.
Shares dipped -1.90% from the previous day's close of $8.97.
During the day across North America, the TSX Composite closed -0.26% at 22813.75, the S&P 500 closed 1.08% at 5564.41, the Dow Jones Industrial Average closed 0.32% at 40415.44 and the Nasdaq Composite closed 1.58% at 18007.57.
Cipher Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker CPH.
A total of 6,764 shares was traded during the session, with total trades of 50, with an average volume of 19,873 in the last five days.
Trading across the entire TSX saw 3,093 price advancers against 2,137 declines and 96 unchanged.
During the prior 52 weeks, CPH.TO has traded as high as $10.33 (May 10,2024) and low as $3.35 (August 08,2023). Moreover, in the last 12 months, Cipher Pharmaceuticals Inc's shares have risen 134.67%, while in 2024, they have soared 58.84%.
Following today's trading, Cipher Pharmaceuticals Inc has a market capitalization of $216.29 million on a float of 24,113 shares outstanding. Its annual EPS is $0.90.
Cipher Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.
Currently, Cipher Pharmaceuticals Inc's consensus rating is "Moderate Buy" based on 2 analysts according to Zacks. Currently, there are 1 buy ratings and 1 hold ratings for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
